Capsiate
Code | Size | Price |
---|
TAR-TN2429-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TN2429-50mg | 50mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Capsiate is a non-pungent analogue of capsaicin with a similar biological profile. It has a role as an anti-allergic agent, a plant metabolite, an antioxidant, an angiogenesis inhibitor, a hypoglycemic agent, an anti-inflammatory agent and a capsaicin receptor agonist. It is a monomethoxybenzene, a carboxylic ester, and a member of phenols.
CAS:
205687-01-0
Formula:
C18H26O4
Molecular Weight:
306.402
Pathway:
Membrane transporter/Ion channel|oxidation-reduction
Purity:
0.98
SMILES:
COc1cc(COC(=O)CCCCC=CC(C)C)ccc1O
Target:
Antioxidant|TRP/TRPV Channel
References
Iida T, et al. TRPV1 activation and induction of nociceptive response by a non-pungent capsaicin-like compound, capsiate. Neuropharmacology. 2003;44(7):958-967.
Pyun BJ, et al. Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity. Cancer Res. 2008;68(1):227-235.
Lee, et al. Capsiate Inhibits DNFB-Induced Atopic Dermatitis in NC/Nga Mice through Mast Cell and CD4+ T-Cell Inactivation. J Invest Dermatol. 2015;135(8):1977-1985.
Haramizu S, et al. Capsiate, a non-pungent capsaicin analog, reduces body fat without weight rebound like swimming exercise in mice. Biomed Res. 2011;32(4):279-28